Nestin promotes pulmonary fibrosis via facilitating recycling of TGF-β receptor I
-
Published:2021-10-08
Issue:
Volume:
Page:2003721
-
ISSN:0903-1936
-
Container-title:European Respiratory Journal
-
language:en
-
Short-container-title:Eur Respir J
Author:
Wang Jiancheng,Lai Xiaofan,Yao Senyu,Chen Hainan,Cai Jianye,Luo Yulong,Wang Yi,Qiu Yuan,Huang Yinong,Wei Xiaoyue,Wang Boyan,Lu Qiying,Guan Yuanjun,Wang Tao,Li Shiyue,Xiang Andy Peng
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that is characterised by aberrant proliferation of activated myofibroblasts and pathological remodelling of the extracellular matrix. Previous studies have revealed that the intermediate filament protein Nestin plays key roles in tissue regeneration and wound healing in different organs. Whether Nestin plays a critical role in the pathogenesis of IPF needs to be clarified.Nestin expression in lung tissues from bleomycin-treated mice and IPF patients was determined. Transfection with Nestin shRNA vectors in vitro that regulated TGF-β/Smad signalling was conducted. Biotinylation assays to observe plasma membrane TβRI, TβRI endocytosis and TβRI recycling after Nestin knockdown were performed. Adeno-associated virus serotype 6 (AAV6)-mediated Nestin knockdown was assessed in vivo.We found that Nestin expression was increased in a murine pulmonary fibrosis model and IPF patients, and that the upregulated protein primarily localised in lung α-SMA+ myofibroblasts. Mechanistically, we determined that Nestin knockdown inhibited TGF-β signalling by suppressing recycling of TβRI to the cell surface and that Rab11 was required for the ability of Nestin to promote TβRI recycling. In vivo, we found that intratracheal administration of adeno-associated virus serotype 6 (AAV6)-mediated Nestin knockdown significantly alleviated pulmonary fibrosis in multiple experimental mice models.In conclusion, our findings reveal a pro-fibrotic function of Nestin partially through facilitating Rab11-dependent recycling of TβRI and shed new light on pulmonary fibrosis treatment.
Funder
Key Scientific and Technological Program of Guangzhou City
Strategic Priority Research Program of the Chinese Academy of Sciences
National Key Research and Development Program of China, Stem cell and Translational Research
Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University
Fundamental Research Funds for the Central Universities
Key Research and Development Program of Guangdong Province
National Natural Science Foundation of China
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献